CTLA4 and cancer: While both studies describe the gut microbiota-dependent intratumoral maturation of DCs, the first study (on anti-CTLA4) suggests a role for cross-reactive T cell epitopes present on bacteria and cancer, the latter (on anti-PD-L1) postulates an effect on innate immunity leading to a gut microbiota-dependent resetting of antigen presenting cell functions.